
    
      Each cycle consists of 28 days. Valemetostat tosylate (DS-3201b) is given continuously at 200
      mg once daily (QD). The total duration is expected to be approximately 3 years, assuming an
      expected enrollment duration of 2 years and a minimum duration of valemetostat tosylate (DS-
      3201b) administration of 12 cycles of 28 days for the last enrolled patient.
    
  